Teucrium Investment Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$825K Sell
688
-435
-39% -$444K 0.73% 28
2026
Q1
$1.03M Sell
1,123
-364
-24% -$369K 0.8% 26
2025
Q4
$1.6M Buy
+1,487
New +$1.42M 1.75% 21

Other funds holding LLY

Teucrium Investment Advisors's LLY Position: Q2 2026 in Review

Teucrium Investment Advisors reduced its Eli Lilly (LLY) stake by 39% in Q2 2026, selling an estimated $444K and leaving 688 shares worth $825K. The position accounts for 0.73% of the portfolio, ranked #28.

Teucrium Investment Advisors first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.6M in Q4 2025. 4,614 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Teucrium Investment Advisors held 688 shares of Eli Lilly worth $825K as of Q2 2026.
  • Teucrium Investment Advisors sold 435 Eli Lilly shares in Q2 2026, an estimated $444K.
  • Eli Lilly made up 0.73% of Teucrium Investment Advisors's portfolio in Q2 2026, its #28 holding.
  • Teucrium Investment Advisors first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • Teucrium Investment Advisors's Eli Lilly position peaked at $1.6M in Q4 2025.
  • 4,614 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Teucrium Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.